These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30735462)

  • 81. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Provider-level rates of HEDIS-consistent HPV vaccination in a regional health plan.
    Panozzo CA; Gilkey MB; Kornides ML; Wharam JF
    Hum Vaccin Immunother; 2019; 15(7-8):1708-1714. PubMed ID: 30735462
    [No Abstract]   [Full Text] [Related]  

  • 83. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
    Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
    Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Supporting Human Papillomavirus Vaccination in Adolescents: Perspectives From Commercial and Medicaid Health Plans.
    Ng JH; Sobel K; Roth L; Byron SC; Lindley MC; Stokley S
    J Public Health Manag Pract; 2017; 23(3):283-290. PubMed ID: 27798527
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey.
    Walling EB; Dodd S; Bobenhouse N; Reis EC; Sterkel R; Garbutt J
    Am J Prev Med; 2019 Jan; 56(1):74-83. PubMed ID: 30573149
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany.
    Rieck T; Feig M; Deleré Y; Wichmann O
    Vaccine; 2014 Sep; 32(43):5564-9. PubMed ID: 25131739
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A model of health care provider decision making about HPV vaccination in adolescent males.
    Alexander AB; Best C; Stupiansky N; Zimet GD
    Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
    [TBL] [Abstract][Full Text] [Related]  

  • 88. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
    Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Advancing Human Papillomavirus Vaccine Delivery: 12 Priority Research Gaps.
    Reiter PL; Gerend MA; Gilkey MB; Perkins RB; Saslow D; Stokley S; Tiro JA; Zimet GD; Brewer NT
    Acad Pediatr; 2018 Mar; 18(2S):S14-S16. PubMed ID: 29502629
    [No Abstract]   [Full Text] [Related]  

  • 90. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.
    Meites E; Kempe A; Markowitz LE
    MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(49):1405-1408. PubMed ID: 27977643
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Primary Care Physicians' Perspectives About HPV Vaccine.
    Allison MA; Hurley LP; Markowitz L; Crane LA; Brtnikova M; Beaty BL; Snow M; Cory J; Stokley S; Roark J; Kempe A
    Pediatrics; 2016 Feb; 137(2):e20152488. PubMed ID: 26729738
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Human Papillomavirus Vaccine Initiation among 9-13-Year-Olds in the United States.
    Donahue KL; Hendrix KS; Sturm LA; Zimet GD
    Prev Med Rep; 2015; 2():892-898. PubMed ID: 26594616
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans - United States, 2013.
    Ng J; Ye F; Roth L; Sobel K; Byron S; Barton M; Lindley M; Stokley S
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(42):1185-9. PubMed ID: 26513219
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Physician communication about adolescent vaccination: How is human papillomavirus vaccine different?
    Gilkey MB; Moss JL; Coyne-Beasley T; Hall ME; Shah PD; Brewer NT
    Prev Med; 2015 Aug; 77():181-5. PubMed ID: 26051197
    [TBL] [Abstract][Full Text] [Related]  

  • 95. HPV vaccine hesitancy: findings from a statewide survey of health care providers.
    McRee AL; Gilkey MB; Dempsey AF
    J Pediatr Health Care; 2014; 28(6):541-9. PubMed ID: 25017939
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention.
    Brewer NT; Chung JK; Baker HM; Rothholz MC; Smith JS
    Gynecol Oncol; 2014 Mar; 132 Suppl 1():S3-8. PubMed ID: 24361732
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.
    Holman DM; Benard V; Roland KB; Watson M; Liddon N; Stokley S
    JAMA Pediatr; 2014 Jan; 168(1):76-82. PubMed ID: 24276343
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evaluation of an intervention providing HPV vaccine in schools.
    Stubbs BW; Panozzo CA; Moss JL; Reiter PL; Whitesell DH; Brewer NT
    Am J Health Behav; 2014 Jan; 38(1):92-102. PubMed ID: 24034684
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010.
    Dorell C; Yankey D; Kennedy A; Stokley S
    Clin Pediatr (Phila); 2013 Feb; 52(2):162-70. PubMed ID: 23221308
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008.
    Wong CA; Berkowitz Z; Dorell CG; Anhang Price R; Lee J; Saraiya M
    Cancer; 2011 Dec; 117(24):5612-20. PubMed ID: 21692069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.